Artiva Biotherapeutics, Inc.
ARTV
$11.78
$0.564.99%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -47.71% | -41.75% | -16.14% | 205.79% | 167.10% |
| Total Receivables | 156.41% | -26.67% | -37.26% | -34.02% | -86.42% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -64.33% | 80.39% | 124.12% | 247.49% | 87.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -47.80% | -40.27% | -13.97% | 199.64% | 158.03% |
|
|
|||||
| Total Current Assets | -47.80% | -40.27% | -13.97% | 199.64% | 158.03% |
| Net Property, Plant & Equipment | -21.60% | -15.03% | -14.18% | -12.80% | -11.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 93.88% | 75.05% | 58.09% | -85.44% | -47.62% |
| Total Assets | -44.60% | -37.52% | -34.01% | 123.14% | 112.13% |
|
|
|||||
| Total Accounts Payable | 12.28% | -68.33% | -30.21% | 47.63% | 37.29% |
| Total Accrued Expenses | -12.80% | 29.87% | -15.80% | -6.05% | 21.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -18.41% | -18.21% | -15.03% | -3.91% | 2.00% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -10.85% | 6.81% | -16.35% | -0.54% | 17.71% |
|
|
|||||
| Total Current Liabilities | -10.85% | 6.81% | -16.35% | -0.54% | 17.71% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -29.66% | -25.73% | -24.17% | -19.98% | -18.52% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -19.45% | -8.59% | -20.17% | -59.78% | -53.57% |
|
|
|||||
| Common Stock & APIC | 1.41% | 1.61% | 1.78% | 1,896.84% | 2,036.80% |
| Retained Earnings | -32.61% | -34.00% | -34.34% | -35.25% | -36.73% |
| Treasury Stock & Other | -- | 179.84% | -74.26% | -98.35% | -- |
| Total Common Equity | -47.95% | -41.08% | -35.71% | 177.99% | 196.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -47.95% | -41.08% | -35.71% | 177.99% | 196.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -47.95% | -41.08% | -35.71% | 488.72% | 304.37% |
|
|
|||||